# Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children

> **NCT07398261** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Menoufia University** · enrollment: 151 (estimated)

## Conditions studied

- Treatment of Non-monosymptomatic Nocturnal Enuresis

## Interventions

- **DRUG:** Mirabegron 25 MG

## Key facts

- **NCT ID:** NCT07398261
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-28
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 151 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398261, "Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07398261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*